These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 17761024

  • 1. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
    Subba Raju BV, Singh R, Sreenivas G, Singh S, Salotra P.
    Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, Ramesh V, Negi NS.
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [Abstract] [Full Text] [Related]

  • 5. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A, Singh S.
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [Abstract] [Full Text] [Related]

  • 6. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M, Majumder HK, Sundar S, Bhaduri AN.
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [Abstract] [Full Text] [Related]

  • 7. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T, Amogne W, Abebe T, Kuhls K, Hailu A, Schönian G.
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [Abstract] [Full Text] [Related]

  • 8. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
    Khanra S, Sarraf NR, Das S, Das AK, Roy S, Manna M.
    Acta Trop; 2016 Dec 01; 164():177-184. PubMed ID: 27629023
    [Abstract] [Full Text] [Related]

  • 11. RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.
    Khanra S, Datta S, Mondal D, Saha P, Bandopadhyay SK, Roy S, Manna M.
    Acta Trop; 2012 Dec 01; 124(3):229-34. PubMed ID: 22960646
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML, Deb M, Karki BM, Sarif M, Khanal B, Bhattacharya SK, Agrawal S, Koirala S.
    Southeast Asian J Trop Med Public Health; 2007 Jul 01; 38(4):619-25. PubMed ID: 17882997
    [Abstract] [Full Text] [Related]

  • 14. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV, Gurumurthy S, Kuhls K, Bhandari V, Schnonian G, Salotra P.
    Parasitol Res; 2012 Oct 01; 111(4):1559-68. PubMed ID: 22752721
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis.
    Salotra P, Duncan RC, Singh R, Subba Raju BV, Sreenivas G, Nakhasi HL.
    Microbes Infect; 2006 Mar 01; 8(3):637-44. PubMed ID: 16469521
    [Abstract] [Full Text] [Related]

  • 16. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
    Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926
    [Abstract] [Full Text] [Related]

  • 17. Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: correlation with clinical outcome.
    Ansari NA, Sharma P, Salotra P.
    Clin Immunol; 2007 Mar 04; 122(3):343-8. PubMed ID: 17218153
    [Abstract] [Full Text] [Related]

  • 18. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.
    Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, Shamsuzzaman AK, Raju BV, Salotra P, Dujardin JC, Schönian G.
    Infect Genet Evol; 2009 Jan 04; 9(1):24-31. PubMed ID: 18957333
    [Abstract] [Full Text] [Related]

  • 19. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P, Singh R.
    Indian J Med Res; 2006 Mar 04; 123(3):295-310. PubMed ID: 16778312
    [Abstract] [Full Text] [Related]

  • 20. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR, Mukhopadhyay S, Banerjee A, Das AK, Roy S, Chakrabarti S, Manna M, Saha P.
    Acta Trop; 2021 Nov 04; 223():106086. PubMed ID: 34389331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.